In addition to its value as a diagnostic biomarker of ILD, KL-6 serum levels have been reported to be of prognostic value for predicting disease severity, acute exacerbations, and patient survival (125, 175, 176). This evidence concerns the gene MUC1 and interstitial lung disease.